Garrison Point Advisors’s AbbVie ABBV Stock Holding History

Garrison Point Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$759K	Sell	3,016 -50	-2%	-$10.8K	0.31%	86
2026 Q1	$667K	Hold	3,066	–	–	0.3%	86
2025 Q4	$701K	Sell	3,066 -872	-22%	-$199K	0.31%	83
2025 Q3	$912K	Buy	3,938 +1,803	+84%	+$367K	0.38%	67
2025 Q2	$396K	Hold	2,135	–	–	0.18%	117
2025 Q1	$447K	Buy	2,135 +500	+31%	+$97.2K	0.22%	106
2024 Q4	$291K	Hold	1,635	–	–	0.14%	131
2024 Q3	$323K	Hold	1,635	–	–	0.2%	112
2024 Q2	$280K	Hold	1,635	–	–	0.19%	118
2024 Q1	$298K	Buy	1,635 +100	+7%	+$17.2K	0.19%	122
2023 Q4	$238K	Hold	1,535	–	–	0.17%	136
2023 Q3	$229K	Hold	1,535	–	–	0.18%	132
2023 Q2	$207K	Hold	1,535	–	–	0.15%	146
2023 Q1	$245K	Buy	+1,535	New	+$235K	0.18%	130

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Garrison Point Advisors's ABBV Position: Q2 2026 in Review

Garrison Point Advisors reduced its AbbVie (ABBV) stake by 1.6% in Q2 2026, selling an estimated $10.8K and leaving 3,016 shares worth $759K. The position accounts for 0.31% of the portfolio, ranked #86.

Garrison Point Advisors first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. The position peaked at $912K in Q3 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Garrison Point Advisors held 3,016 shares of AbbVie worth $759K as of Q2 2026.
Garrison Point Advisors sold 50 AbbVie shares in Q2 2026, an estimated $10.8K.
AbbVie made up 0.31% of Garrison Point Advisors's portfolio in Q2 2026, its #86 holding.
Garrison Point Advisors first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
Garrison Point Advisors's AbbVie position peaked at $912K in Q3 2025.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Garrison Point Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.